Healthcare & Life Sciences

Qu Biologics

1
Investors

About

Develops a site-specific immunotherapy platform to treat cancer and other immune-related diseases.

Explore Qu Biologics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.